CliffBio
small molecule

JAVADIN

CLONIDINE HYDROCHLORIDE

Loss of exclusivityJuly 2042latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameJAVADIN
Active ingredientCLONIDINE HYDROCHLORIDE
Strength0.02MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2025
Marketing statusRX

Listed patents

PatentExpiresType
12233049July 2042product
12440474July 2042product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.